The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs

Annals of Tropical Medicine and Parasitology

Volumn 101, Issue 5, 2007, Pages 391-398

  Quashie, N B ^a,b,c   Duah, N O ^a   Abuaku, B ^a   Koram, K A ^a  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; HALOFANTRINE; MEFLOQUINE; QUININE; VERAPAMIL;

ARTICLE; CHILD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; GHANA; HUMAN; IC 50; IN VITRO STUDY; INFANT; MAJOR CLINICAL STUDY; MALARIA; MONOTHERAPY; NONHUMAN; PLASMODIUM FALCIPARUM;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; GHANA; HUMANS; INFANT; MALARIA, FALCIPARUM; MEFLOQUINE; PHENANTHRENES; PLASMODIUM FALCIPARUM; QUININE; SESQUITERPENES;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 34748906565     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/136485907X176553     Document Type: Article

References (25)

1. Afari, E. A., Akanmori, B. D., Nakano, T. & Ofori-Adjei, D. (1992). Plasmodium falciparum: sensitivity to chloroquine in vivo in three ecological zones in Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene, 86, 231-232.
2. Afari, E. A., Akanmori, B. D., Nakano, T. & Ofori-Adjei, D. (1993). In vitro responses of P. falciparum parasites to chloroquine, amodiaquine and quinine in two ecological zones in Ghana. Central African Journal of Medicine, 39, 136-140.
3. Bray, P. G., Mungthin, M., Ridley, R. G. & Ward, S. A. (1998). Access to hematin: the basis of chloroquine resistance. Molecular Pharmacology, 54, 170-179.
4. Churchill, F. C., Patchen, L. C., Campbell, C. C., Schwanz, I. K., Nguyen-Dinh, P. & Dickinson. C. M. (1985). Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sciences, 36, 53-62.
5. Djimdé, A., Doumbo, O. K., Cortese, J. F., Kayentao, K., Doumbo, S., Diourté, Y., Dicko, A., Su, X. Z., Nomura, T., Fidock, D. A., Wellems, T. E., Plowe, C. V. & Coulibaly, D. (2001). A molecular marker for chloroquine-resistant falciparum malaria. New England Journal of Medicine, 344, 257-263.
6. Driessen, G. J., van Kerkhoven, S., Schouwenberg, B. J., Bonsu, G. & Verhave, J. P. (2002). Sulphadoxine/pyrimethamine: an appropriate first-line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age. Tropical Medicine and International Health, 7, 577-583.
7. Ehrhardt, S., Mockenhaupt, F. P., Eggelte, T. A., Agana-Nsiire, P., Stollberg, K., Anemana, S. D., Otchwemah, R. N. & Bienzle, U. (2003). Chloroquine blood concentrations and molecular markers of chloroquine-resistant Plasmodium falciparum in febrile children in northern Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 697-701.
8. Famin, O. & Ginsburg, H. (2002). Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes. Biochemical Pharmacology, 63, 393-398.
9. Ginsburg, H., Famin, O., Zhang, J. & Krugliak, M. (1998). Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochemical Pharmacology, 56, 1305-1313.
10. Kilimali, V. A., Mkufya, A. R. & Kilama, W. L. (1989). Low resistance of Plasmodium falciparum to mefloquine in Tanga region, Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 83, 162-164.
11. Koram, K. A., Abuaku, B., Duah, N. & Quashie, N. (2005). Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Tropica, 95, 194-203.
12. Landgraf, B., Kollaritsch, H., Wiedermann, G. & Wernsdorfer, W. H. (1994). Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 440-442.
13. Li, X. Q., Bjorkman, A., Andersson, T. B., Ridderstrom, M. & Masimirembwa, C. M. (2002). Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. Journal of Pharmacology and Experimental Therapeutics, 300, 399-407.
14. Mariga, S. T., Gil, J. P., Sisowath, C., Wernsdorfer, W. H. & Bjorkman, A. (2004). Synergism between amodiaquine and its major metabolite, desethylamodiaquine against Plasmodium falciparum in vitro. Antimicrobial Agents and Chemotherapy, 48, 4089-4096.
15. Martin, S. K., Oduola, A. M. & Milhous, W. K. (1987). Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science, 235, 899-901.
16. Neequaye, J. (1986). In vivo chloroquine-resistant falciparum in western Africa. Lancet, i, 153.
17. Ochong, E. O., van den Broek, I. V., Keus, K. & Nzila, A. (2003). Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. American Journal of Tropical Medicine and Hygiene, 69, 184-187.
18. Oduro, A. R., Anyorigiya, T., Hodgson, A., Ansah, P., Anto, F., Ansah, N. A., Atuguba, F., Mumuni, G. & Amankwa, J. (2005). A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. Tropical Medicine and International Health, 10, 279-284.
19. Ofori-Adjei, D., Adjepon-Yamoah, K. K., Commey, J. O. O. & Ofori-Adjei, E. (1988). In-vivo sensitivity of P. falciparum to chloroquine in Accra, Ghana. Ghana Medical Journal, 22, 11-14.
20. Quashie, N. B., Ofori-Adjei, D., Duah, N. O. & Koram, K. A. (2004). In vitro susceptibility of Plasmodium falciparum isolates to chloroquine and other antimalarial drugs in Ghana. Ghana Medical Journal, 38, 131-135.
21. Quashie, N. B., Akanmori, B. D., Goka, B. Q., Ofori-Adjei, D. & Kurtzhals, J. A. (2005). Pretreatment blood concentrations of chloroquine in patients with malaria infection: relation to response to treatment. Journal of Tropical Pediatrics, 51, 149-153.
22. Ter Kuile, F. O., Dolan, G., Nosten, F., Edstein, M. D., Luxemburger, C., Phaipun, L., Chongsuphajaisiddhi, T., Webster, H. K. & White, N. J. (1993). Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet, 341, 1044-1049.
23. World Health Organization (2002). Monitoring Antimalarial Drug Resistance: Report of a WHO Consultation. Geneva, Switzerland 3-5 December 2001. Document WHO/CDS/CSR/EPH/2002.17. Geneva: WHO.
24. World Health Organization (2001a). Antimalarial Drug Combination Therapy: Report of a WHO Technical Consultation, 4-5 April 2001. Document WHO/CDS/RBM/2001.35. Geneva: WHO.
25. World Health Organization (2001b). In Vitro Micro-test (Mark III) for the Assessment of the Response of Plasmodium falciparum to Chloroquine, Mefloquine, Sulphadoxine/pyrimethamine and Amodiaquine. Document CTD/MAL/97.20 Revision 2. Geneva: WHO.